A 68-year-old man is evaluated in the intensive care unit due to difficulty weaning from m… — USMLE Step 2 CK

A $68$ -year-old man is evaluated in the intensive care unit due to difficulty weaning from mechanical ventilation. He was intubated $5$ days ago for acute hypercapnic respiratory failure secondary to a severe chronic obstructive pulmonary disease exacerbation. Initial treatment included bronchodilators, systemic glucocorticoids, empiric antibiotics, and aggressive diuresis with intravenous furosemide due to concurrent right ventricular failure and severe peripheral edema.

Over the last $24$ hours, his clinical status has improved. His chest radiograph shows clear lung fields, and he has minimal endotracheal secretions. A spontaneous breathing trial was attempted but was aborted after $15$ minutes due to rapid shallow breathing and a respiratory rate of $32$ /min. Current vital signs are temperature $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), heart rate $88$ /min, and blood pressure $132/82\text{ mm Hg}$ .

Laboratory studies show:

Laboratory Test	Result
Sodium	$139\text{ mEq/L}$
Potassium	$3.2\text{ mEq/L}$
Chloride	$86\text{ mEq/L}$
Bicarbonate	$39\text{ mEq/L}$
Blood urea nitrogen	$38\text{ mg/dL}$
Creatinine	$1.2\text{ mg/dL}$

Arterial blood gas on pressure support ventilation (FiO $_2$ $30\%$ , PEEP $5\text{ cm H}_2\text{O}$ , pressure support $8\text{ cm H}_2\text{O}$ ) reveals:

Parameter	Result
pH	$7.53$
PaCO $_2$	$52\text{ mm Hg}$
PaO $_2$	$84\text{ mm Hg}$

Which of the following is the most appropriate next step in management to facilitate ventilator weaning in this patient?

Intravenous acetazolamide administrationCevap
B
Intravenous normal saline infusion
C
Escalation to broad-spectrum antimicrobial therapy
D
Administration of additional intravenous furosemide
E
Transition to assist-control ventilation to increase minute ventilation

Cevap

The correct answer is the administration of intravenous acetazolamide to correct the metabolic alkalosis and restore the patient's respiratory drive.

The correct option addresses the patient's inability to wean from the ventilator due to severe metabolic alkalosis (

pH

7.53

, bicarbonate

39\text{ mEq/L}

). In patients with severe COPD, chronic respiratory acidosis is common and leads to compensatory renal bicarbonate retention. When aggressively treated with loop diuretics (like furosemide) for right heart failure, patients lose chloride, potassium, and volume, resulting in a severe contraction alkalosis. This resulting alkalemia blunts the respiratory drive because the body attempts to retain CO

_2

to normalize the pH, causing the patient to take rapid, shallow breaths and fail spontaneous breathing trials. The most appropriate treatment is to correct the metabolic alkalosis. Although normal saline can correct chloride-responsive metabolic alkalosis, volume expansion is contraindicated in this patient given the recent history of right ventricular failure and severe edema. Acetazolamide, a carbonic anhydrase inhibitor, promotes renal bicarbonate excretion. This effectively corrects the alkalosis and stimulates the respiratory drive without risking volume overload.

Adım Adım Çözüm

Analyze the arterial blood gas and basic metabolic panel to identify the primary disturbance.

The pH is 7.53 (alkalemia). Bicarbonate is significantly elevated at 39 mEq/L, and PaCO2 is elevated at 52 mm Hg. The primary disturbance is a metabolic alkalosis with compensatory respiratory acidosis.

Identifying the acid-base disorder is essential to understand why the patient is failing the spontaneous breathing trial.

Determine the etiology of the metabolic alkalosis and its clinical impact.

The alkalosis is caused by aggressive furosemide diuresis leading to chloride, potassium, and volume depletion (contraction alkalosis). This severe alkalemia blunts the patient's respiratory drive as the body tries to retain CO2, preventing successful weaning from mechanical ventilation.

Understanding the pathophysiologic mechanism dictates the specific therapeutic intervention.

Select the safest intervention to correct the alkalosis.

While intravenous normal saline can correct chloride-responsive alkalosis, it is hazardous due to the patient's recent right ventricular failure. Acetazolamide safely corrects the alkalosis by inducing renal bicarbonate diuresis.

Choosing a therapy that avoids volume overload in a vulnerable cardiac patient is critical for safe management.

Anahtar Kavram

Severe metabolic alkalosis blunts the respiratory drive and can cause failure to wean from mechanical ventilation; in patients who cannot tolerate volume expansion (e.g., recent right heart failure), acetazolamide is the treatment of choice to induce a bicarbonate diuresis.

Tahmini Süre:1m 30s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru